Skip to main content

Table 1 Baseline characteristics of patients with and without echocardiographic abnormality indicative of heart failure

From: Evaluation of B-type Natriuretic Peptide for validation of a heart failure register in primary care

 

Echocardiogram not consistent with heart failure (n = 24)

Echocardiogram consistent with heart failure (n = 32)

p value

Age – mean (SD)

75.4 (7.2)

78.3 (8.4)

0.184 (t-test)

Male gender

13 (54.2%)

13 (40.6%)

0.315

Ischaemic heart disease

7 (29.2%)

16 (50.0%)

0.117

Hypertension

12 (50.0%)

14 (43.8%)

0.643

Diabetes

4 (16.7%)

9 (28.1%)

0.315

Atrial fibrillation

3 (12.5%)

6 (18.8%)

0.529

Peripheral vascular disease

2 (8.3%)

2 (6.3%)

0.765

Chronic airflow limitation

6 (25.0%)

5 (15.6%)

0.382

Diuretic

21 (87.5%)

24 (75.0%)

0.244

Angiotensin converting enzyme inhibitor or Angiotensin receptor blocker

14 (58.3%)

23 (71.9%)

0.290

Beta-blocker

2 (8.3%)

8 (25.0%)

0.107

Statin

9 (37.5%)

14 (43.8%)

0.638

Abnormal ECG

13 (54.2%)

27 (84.4%)

0.013

BNP (pmol/l) median (interquartile range)

11.7 (20.0)

32.75 (35.8)

0.010 (Mann-Whitney test)

  1. Note – values are number (percentage) unless stated. P values refer to chi-squared tests unless stated.